Motivation: DNA microarrays are now capable of providing genome-wide patterns of gene expression across many di erent conditions. The rst level of analysis of these patterns requires determining whether observed differences in expression are signi cant or not. Current methods are unsatisfactory due to the lack of a systematic framework that can accommodate noise, variability, and low replication often typical of microarray data.
Introduction
DNA gene expression microarrays allow biologists to study genome-wide patterns of gene expression Eisen et al., 1998; Holstege et al., 1998) . In these arrays, total RNA is reverse-transcribed to create either radioactive-or uorescent-labeled cDNA which is hybridized with a large DNA library of gene fragments attached to a glass or membrane support. Phosphorimaging or other imaging techniques are used to produce expression measurements for thousands of genes under various experimental conditions. Use of these arrays is rapidly creating terabytes of information, potentially capable of providing fundamental insights into biological processes ranging from gene function, to development, to cancer Alon et al., 1999; Lee et al., 1999; White et al., 1999; Ly et al., 2000) . Unfortunately, data analysis techniques for microarray data are still at an early stage of development (Zhang, 1999) . Our goal here is to develop a general Bayesian statistical framework for the analysis of array data.
Gene expression array data can be analyzed on at least three levels of increasing complexity. First, the level of single genes, where one seeks to establish whether each gene in isolation behaves di erently in a control versus a treatment situation. The second level considers gene combinations, where clusters of genes are analyzed in terms of common functionalities, interactions, co-regulation, and so forth. The third level attempts to infer the underlying regulatory regions and gene/protein networks that ultimately are responsible for the patterns observed. This paper focuses on the rst level of analysis.
For simplicity, we assume that for each gene X we have a set of measurements x c 1 ; : : : ; x c nc and x t 1 ; : : : ; x t nt representing expression levels, or rather their logarithms, in both a control and treatment situation. Treatment is of course taken in a broad sense to mean any condition di erent from the control. For each gene, the fundamental question we wish to address is whether the level of expression is signi cantly di erent in the two situations. While it might seem that standard statistical techniques could easily address such a problem, this is in fact not the case.
One approach commonly used in the current literature is a simple-minded fold approach, in which a gene is declared to have signi cantly changed if its average expression level varies by more than a constant factor, typically 2, between the treatment and control conditions. Inspection of gene expression data suggests, however, that such a simple \2-fold rule" is unlikely to yield optimal results, since a factor of 2 can have quite di erent signi cance depending on expression levels.
A related approach to the same question is the use of a t-test, for instance on the logarithm of the expression levels. This is similar to the fold approach because the di erence between two logarithms is the logarithm of their ratio. This approach is not necessarily identical to the rst because the logarithm of the mean is not equal to the mean of the logarithms; in fact it is always strictly greater, by convexity of the logarithm function. But with a reasonable degree of approximation, a test of the signi cance of the di erence between the log expression levels of two genes is equivalent to a test of whether or not their fold change is signi cantly di erent from 1. 
degrees of freedom. When t exceeds a certain threshold depending on the con dence level selected, the two populations are considered to be di erent. Because in the t-test the distance between the population means is normalized by the empirical standard deviations, this has the potential for addressing some of the shortcomings of the xed fold-threshold approach. The fundamental problem with the t-test for microarray data, however, is that the repetition numbers n c and/or n t are often small because experiments remain costly or tedious to repeat, even with current technology. Small populations of size n = 1; 2 or 3 are still very common and lead, for instance, to signi cant underestimates of the variances. Thus a better framework is needed to address these shortcomings.
Here we develop a Bayesian probabilistic framework for microarray data, which bears some analogies with the framework used for sequence data (Baldi & Brunak, 1998) and addresses the problem of detecting gene di erences. Because a complete Bayesian treatment is computationally demanding, we also develop approximate computational shortcuts to strike a balance between rigor and computational e ciency. In particular, we develop methods for the regularization of the t-test approach.
2 Bayesian probabilistic framework
Several decades of research in sequence analysis and other areas have demonstrated the advantages and effectiveness of probabilistic approaches to biological data. Indeed, DNA microarray data is characterized by a high degree of measurement noise and variability. Biological systems also have very high dimensionality: even in a large array experiment, only a very small subset of relevant variables is measured, or even under control. The vast majority of variables remains hidden and must be inferred or integrated out by probabilistic methods. The general Bayesian statistical framework codi es how to proceed with data analysis and inference in a rational way. Under a small set of common sense axioms, it can be shown remarkably that subjective degrees of belief must obey the rules of probability and proper induction must proceed in a unique way, by propagation of information through Bayes theorem. In particular, at any given time, any hypothesis or model M can be assessed by computing its posterior probability in light of the data according to Bayes theorem:
, where P(DjM) is the data likelihood and P(M) is the prior probability capturing any background information one may have.
Probabilistic modeling of microarray data
In sequence data, the most simple probabilistic model is that of a die (Figure 1) , associated with the average composition of the family of DNA, RNA, or protein sequences under study. The next level of modeling complexity is a rst-order Markov model with one die per position or per column in a multiple alignment. In spite of their simplicity, these models are routinely used, for instance as a background models against which the performances of more sophisticated models can be assessed.
In array data, the simplest model would assume that all data points are independent from each other and extracted from a single continuous distribution, for instance a Gaussian distribution. While trivial, this Gaussian die model still requires the computation of interesting quantities, such as the average level of activity and its standard deviation, which can be useful to calibrate or assess global properties of the data. The next equivalent level of modeling is a set of independent distributions, one for each dimension, i.e. for instance each gene. While it is obvious that genes interact with each other in complex ways and therefore are not independent, the independence approximation is still useful and underlies any attempt, probabilistic or other, to determine whether expression level di erences are signi cant solely on a gene-by-gene basis.
Here we rst assume that the expression-level measurements of a gene in a given situation have a roughly Gaussian distribution. In our experience, with common technologies this assumption is reasonable, especially for the logarithm of the expression levels, corresponding to lognormal raw expression levels. To the best of our knowledge, large-scale replicate experiments have not been carried out yet to make more precise assessments. It is clear, however, that other distributions, such as gammas or mixtures of Gaussians/gammas, could be introduced at this stage. These would impact the details of the analysis (see also (Wiens, 1999) ), but not the general Bayesian probabilistic framework.
Thus, in what follows we assume that the data has been pre-processed{taking logarithms if needed{to the point where we can model the corresponding measurements of each gene in each situation (treatment or control) with a normal distribution N(x; ; Here and everywhere else, we write C to denote the normalizing constant of any distribution. All the information about the sample that is relevant for the likelihood is summarized in the su cient statistics n, m, and s 2 . The case in which either the mean or the variance of the Gaussian model is supposed to be known is of course easier and is well studied in the literature (Box & Tiao, 1973; Pratt et al., 1995) .
Priors
A full Bayesian treatment requires introducing a prior distribution P( ; 2 ). The choice of a prior is part of the modeling process, and several alternatives (Box & Tiao, 1973; Pratt et al., 1995) are possible, a sign of the exibility of the Bayesian approach rather than its arbitrariness. Several kinds of priors for the mean and variance of a normal distribution have been studied in the literature, including the non-informative improper prior and the conjugate prior. For microarray data, the conjugate prior seems to be more suitable and exible, not only because of its convenient form, but also because it incorporates the basic observation that and 2 are typically not independent.
The conjugate prior When both the prior and the posterior have the same functional form, the prior is said to be a conjugate prior. When estimating the mean alone of a normal model of known variance, the obvious conjugate prior is also a normal distribution. In the case of dice models for biological sequences, the standard conjugate prior is a Dirichlet distribution (Baldi & Brunak, 1998) . The form of the likelihood in Equation 3 shows that the conjugate prior density must also The parameters of the posterior combine information from the prior and the data in a sensible way. The mean n is a convex weighted average of the prior mean and the sample mean. The posterior degree of freedom n is the prior degree of freedom plus the sample size. The posterior sum of squares n 2 n is the sum of the prior sum of squares 0 2 0 , the sample sum of squares (n?1)s 2 , and the residual uncertainty provided by the discrepancy between the prior mean and the sample mean.
While it is possible to use a prior mean 0 for gene expression data, in many situations it is su cient to use 0 = m. The posterior sum of squares is then obtained precisely as if one had 0 additional observations all associated with deviation 2 0 . While super cially this may seem like setting the prior after having observed the data (MacKay, 1992), a similar e ect is obtained using a preset value 0 with 0 ! 0, i.e., with a very broad standard deviation so that the prior belief about the location of the mean is essentially uniform and vanishingly small. The selection of the hyperparameters for the prior is discussed in more detail below.
It can readily be shown that the conditional posterior distribution P( j 2 ; D; ) of the mean is normal N( n ; 2 = n ), the marginal posterior P( jD; ) of the mean is Student t( n ; n ; 2 n = n ), and the marginal posterior P( 2 jD; ) of the variance is scaled inverse gamma I( n ; 2 n ). In the literature, semi-conjugate prior distributions also are used where the functional form of the prior distributions on and 2 are the same as in the conjugate case (normal and scaled inverse gamma, respectively) but independent of each other, i.e. P( ; 2 ) = P( )P ( 2 ). However, as previously discussed, this assumption of independence is unlikely to be suitable for DNA microarray data. More complex priors also could be constructed using mixtures, a mixture of conjugate priors leading to a mixture of conjugate posteriors.
3 Parameter point estimates However, it can be useful to collapse this informationrich distribution into single point estimates. This can be done in a number of ways. In general, the most robust answer is obtained using the mean of the posterior (MP) estimate. An alternative is to use the mode of the posterior, or MAP (maximum a posteriori) estimate. For completeness, we derive and compare both kinds of estimates for the conjugate prior. By integration, the MP estimate is given by 
In practice, Equations 13 and 15 give similar results and can be used with gene expression arrays. The slight di erences between the two closely parallel what is seen with Dirichlet priors on sequence data (Baldi & Brunak, 1998) , Equation 13 generally being a slightly better choice. The Dirichlet prior is equivalent to the introduction of pseudo-counts to avoid setting the probability of any amino acid or nucleotide to zero. In array data, few observation points are likely to result in a poor estimate of the variance. With a single point (n = 1), for instance, we certainly want to refrain from setting the corresponding variance to zero; hence the need for regularization, which is achieved by the conjugate prior. In the MP estimate, the empirical variance is modulated by 0 \pseudo-observations" associated with a background variance ) and w t = ( t ; 2 t ); two sets of hyperparameters c and t ; and two posterior distributions P(w c jD; c ) and P(w t jD; t ). A full probabilistic treatment would require introducing prior distributions over the hyperparameters. These could be integrated out to obtain the true posterior probabilities P(w c jD) and P(w t jD), which then could be integrated over all values of w t and w c to determine whether the two models are di erent or not. Notice that this approach is signi cantly more general than the plain t-test and could in principle detect interesting changes that are beyond the scope of the t-test or fold approaches. For instance, a gene with the same mean but a very di erent variance between the control and treatment situations goes undetected by these methods, although the change in variance might be biologically relevant. Even if we restrict ourselves to an analysis of the means c and t only, the probability P( c t jD; t ; c ) must be computed, and would typically require numerical integration. While the latter can be performed easily on today's computers, here we use a simple approximation strategy to the full Bayesian treatment that relies solely on point estimates.
Point estimates, however, require determining hyperparameter values, and this can be addressed in a number of ways (MacKay, 1992; MacKay, 1999) . Here again, one possibility is to de ne a prior on the hyperparameters and try to integrate them out in order to compute the true posterior P(wjD) and determine the location of its mode, leading to true MAP estimates of w. More precisely, this requires integrating P(wj ) and P(wj jD) with respect to the hyperparameter vector . An alternative that avoids the integration of the hyperparameters is the evidence framework described in (MacKay, 1992) . In the evidence framework, we compute point estimates of the hyperparameters by MAP estimation (MP would again require integrating over hyperparameters) over the posterior P( jD) = P(Dj )P ( ) P(D) (17) If we take a uniform prior P( ), then this is equivalent to maximizing the evidence P(Dj ) P(Dj ) = P(Djw; )P (wj )=P (wjD; ) = P(Djw)P(Wj )=P (wjD; ) (18) In principle, computing the evidence requires integrating out the parameters w of the model. Using the expression for the likelihood and the conjugate prior and posterior, however, we can here obtain the evidence without integration, directly from Equation 18 P(Dj ) = (2 ) ?n=2
The partial derivatives and critical points of the evidence are discussed in the Appendix, where it is shown, for instance, that the mode is achieved for 0 = m. formed on both the raw data and the log-transformed data.
In the simplest case, where we use 0 = m, we must select the values of the background standard deviation 2 0 , and its strength 0 . The parameter 0 represents the degree of con dence in the background variance 2 0 versus the empirical variance. In Cyber-T, the value of 0 can be set by the user by clicking on the corresponding button. The smaller n, the larger 0 ought to be. A simple rule of thumb is to assume that K > 2 points are needed to properly estimate the standard deviation and keep n + 0 = K. This allows for a exible treatment of situations in which the number n of available data points varies from gene to gene. In our current implementation, we use a default of K = 10. A special case can be made for genes with activity levels close to the minimal detection level of the technology being used. The measurements for these genes being particularly unreliable, it may be wise to use a stronger prior for them with a higher value of 0 (this feature is currently not implemented). For 0 , one could use the standard deviation of the entire set of observations or, depending on the situation, of particular categories of genes. We favored a exible implementation under which the background standard deviation is estimated by pooling together all the neighboring genes contained in a window of size w. Cyber-T automatically ranks the expression levels of all the genes and lets the user choose this window size using the corresponding button. The default is w = 101, corresponding to 50 genes immediately above and below the gene under consideration. Adaptive window sizes are brie y discussed in the last section, together with the possibility of deriving regression estimates of 2 0 .
Simulations
We have used the Bayesian approach and Cyber-T to analyze a number of published and unpublished data sets. In every high density array experiments we have analyzed, we have observed a strong scaling of the expression variance over replicated experiments with the average expression level (on both a log-transformed and raw scale). As a result, a threshold for signi cance based solely on fold changes is likely to be too liberal for genes expressed at low levels and too conservative for highly expressed genes. While several biologically relevant results are reported elsewhere (Long et al., 2001 ), we have found that the Bayesian approach compares favorably to a simple fold approach or a straight t-test and partially overcomes de ciencies related to low replication in a statistically consistent way.
One particularly informative data set for comparing the Bayesian approach to simple t-test or fold change is the high density array experiment reported in (Ar n et al., 2000) comparing Escherichia coli cells that were wild type to cells that were mutant for the global regulatory protein IHF (integration host factor). The main advantage of this data set is its four-fold replication for both wild type and mutant alleles. The regularizing effect of the Cyber-T prior based on the background standard deviation is shown for this data in Figure 2 and in the simulation described below. The gure clearly shows that standard deviations vary substantially over the range of expression levels, in this case roughly in a monotonic decreasing fashion, although other behaviors also have been observed. Interestingly, in these plots the variance in log-transformed expression levels is higher for genes expressed at lower levels rather than at higher ones. These plots con rm that genes expressed at low or near background levels may require a stronger value of 0 , or alternatively could be ignored in expression analyses. The variance in the measurement of genes expressed at a low level is large enough that in many cases it will be di cult to detect signi cant changes in expression for this class of loci.
In analyzing the data we found that large fold changes in expression were often associated with p-values not indicative of statistical change in the Bayesian analysis, and conversely subtle fold changes were often highly signi cant as judged by the Bayesian analysis. In these two situations, the conclusions drawn using the Bayesian approach appear robust relative to those drawn from fold change alone, as large non-statistically signi cant fold changes were often associated with large measurement errors, and statistically signi cant genes showing less than two fold changes were often measured very accurately. As a result of the level of experimental replication seen in (Ar n et al., 2000), we were able to look at the consistency of the Bayesian estimator relative to the t-test. We found that in independent samples of size 2 drawn from the IHF data set (i.e., two experiments versus two controls) the set of 120 most signi cant genes identi ed using the Bayesian approach had approximately 50% of their members in common, whereas the set of 120 most signi cant genes identi ed using the ttest had only approximately 25% of their members in common. This suggests that for two fold replication the Bayesian approach is approximately twice as consistent as a simple t-test at identifying genes as up-or downregulated, although with only two fold replication there is a great deal of uncertainty associated with high density array experiments. To further assess the Bayesian approach, here we simulate an arti cial data set assuming Gaussian distribution of log expressions, with means and variances in ranges similar to those encountered in the data set of (Ar n et al., 2000) , with 1000 replicates for each parameter combination. Selected means for the log data and associated standard deviations (in brackets) are as follows: -6 (0.1), -8 (0.2), -10 (0.4), -11 (0.7), -12 (1.0). On this arti cially generated data, we can compare the behavior of a simple ratio (2-fold and 5-fold) approach, with a simple t-test, with the Bayesian t-test using the default settings of Cyber-T. The main results, reported in Table  1 , can be summarized as follows:
By 5 replications (5 control and 5 treatment) the Bayesian approach and t-test give similar results. When the number of replicates is\low" (2 or 3), the Bayesian approach performs better than the t-test The false positive rate on the ratios is a function of expression level and is much higher at lower expression levels. At low expression levels the false positive rate on the ratios is unacceptably high.
For a given level of replication the Bayesian approach at p < 0:01 detects more di erences than a 2-fold change except for the case of low expression levels (where the false positive rate from ratios is elevated).
The Bayesian approach with 2 replicates outperforms the t-test with 3 replicates (or 2 versus 4 replicates).
The Bayesian approach has a similar level of performance when comparing 3 treatments to 3 controls, or 2 treatments to 4 controls. This suggests an experimental strategy where the controls are highly replicated and a number of treatments less highly replicated.
Discussion and Extensions
We have developed a probabilistic framework for array data analysis to address a number of current approach shortcomings related to small sample bias and the fact that fold di erences have di erent signi cance Table 1 : Number of positives detected out of 1000 genes). Data was generated using normal distribution on a log scale in the range of Ar n et al. 2000, with 1000 replicates for each parameter combination. Means of the log data and associated standard deviations (in brackets) are as follows: -6 (0.1), -8 (0.2), -10 (0.4), -11 (0.7), -12 (1.0). For each value of n, the rst three experiments correspond to the case of no change and therefore yield false positive rates. Analysis was carried out using Cyber-T with default settings (w = 101, K = 10) and degrees of freedom n + 0 ? 2. at di erent expression levels. The framework is a form of hierarchical Bayesian modeling with Gausssian geneindependent models. Although the Gaussian representation requires further testing, other distributions can easily be incorporated in a similar framework. As a rst step, we have implemented a regularized t-test approach that is only a shortcut with respect to the full Bayesian treatment. While there can be no perfect substitute for experimental replication (see also (Lee et al., 2000) ), we have shown nonetheless that this approach is e ective and indeed has a regularizing e ect on the data. In particular, in controlled experiments, it compares favorably with a standard fold approach or a conventional t-test.
Depending on goals and implementation constraints, the method can be extended in a number of directions. For instance, regression functions could be computed oline to establish the relationship between standard deviation and expression levels and used to produce background standard deviations. Another possibility is to use adaptive window sizes to compute the local background variance, where the size of the window could depend, for instance, on the derivative of the regression function. In an expression range in which the standard deviation is relatively at (i.e. between -8 and -4 in Figure 2 ), the size of the window is less relevant than in a region where the standard deviation varies rapidly (i. e., between -12 and -10 in Figure 2) . A more complete Bayesian approach could also be implemented, for instance integrating the marginal posterior distributions, which in the case considered here are Student distributions), to estimate the probability P( c t jD; t ; c ).
The approach also can be extended to more complex designs and/or designs involving gradients of an experimental variable and/or time series designs. Examples would include a design in which cells are grown in the presence of di erent stressors (urea, ammonia, oxygen peroxide), or when the molarity of a single stressor is varied (0, 5, 10 mM). Generalized linear and non-linear models can be used in this context.
The most challenging problem, however, is to extend the probabilistic framework towards the second level of analysis, taking into account possible interactions and correlations amongst genes. If two or more genes have similar behavior in a given treatment situation, decisions regarding their expression changes can be made more robustly at the level of the corresponding cluster. A number of ad hoc clustering procedures have been applied to DNA microarray data Alon et al., 1999; Haussler et al., 1999; Heyer et al., 1999; Tamayo et al., 1999) (20) The conjugate prior, generalizing the normal-scaledinverse-gamma distribution, is based on the inverse Wishart distribution (Appendix) which generalizes the scaled inverse gamma distribution and provides a prior on . In analogy with the one-dimensional case, the Thus estimates similar to Equation 13 can be derivedin this multidimensional case.
Bayesian methods are being applied increasingly to a variety of data-rich domains. Whether or not one subscribes to the axioms and practices of Bayesian statistics (Box & Tiao, 1973; Berger, 1985; Pratt et al., 1995) , it is wise to model biological data in general, and microarray data in particular, in a probabilistic manner for the reasons outlined in Section 2. Besides DNA microarrays, there are several other kinds of biological arrays, at different stages of development, that could bene t from a similar probabilistic treatment. By enabling the combinatorial interaction of a large number of molecules with a large library, these high-throughput approaches are rapidly generating terabytes of information, which are overwhelming conventional methods of biological analysis. Going directly to a systematic probabilistic framework may contribute to the acceleration of the discovery process by avoiding some of the pitfalls observed in the history of sequence analysis, where it took several decades for probabilistic models to emerge as the proper framework.
Appendix:
Estimating hyperparameters from the evidence Cyber-T is particularly suited to experimental designs in which replicate control cDNA samples are compared to replicate experimental cDNA samples. The program calculates basic summary statistics, performs statistical analyses to determine whether observed di erences between the control and experimental values are likely to be real, and automatically produces a number of useful plots of the data.
Cyber-T is designed to accept data in the large data spreadsheet format, which is generated as output by software typically used to analyze array experiment images. An element may correspond to a single spot on the array (typical of membrane-or glass slide-based arrays) or a set of spots (typical of GeneChips (Fodor et al., 1991; Lipschutz et al., 1999) ) designed to query labeled RNA. We will refer to these elements as genes or gene probes since each element is generally designed to query a gene. For each gene, data consists of background-subtracted expression levels for both experimental and control treatment. It is assumed that data from independent hybridization experiments within a given experiment treatment will be contained in adjacent columns. Each gene will have a number of \labels" that identify a number of properties of that gene contained in adjacent columns. Examples of labels include: gene name, map location of gene, function of gene, and mRNA length. In order to use Cyber-T, this data matrix should be saved on the user's computer as a tab-delimited text le with column headings removed or pre xed with the hash character (#). Extra blank lines at the end of the le should be removed. These data are uploaded to Cyber-T using the \Browse" button in the Cyber-T browser window. After uploading the data le, the user de nes the columns on which analysis will be performed. Missing data should be coded as \NA" and data that are at or below background should be coded as \0" and treated as the \lowest expression level reliably detected", which is de ned as the 0.0025 percentile associated with all detected genes. Detailed instructions for using Cyber-T can be found on the corresponding web page.
All statistical analysis is carried out using the hdarray library of functions written in R. R is a freely available statistical analysis environment (http://cran.rproject.org) adhering to the Open Source development model (http://www.ci.tuwien.ac.at/R/). The hdarray functions are normally invoked through the Cyber-T Web-based interface, but also can be used directly and extended or modi ed through an X-Window interface (http://www.x.org/about x.htm) to R. A brief tutorial on how to analyze data directly in R is available at http://genomics.biochem.uci.edu/CyberT/, together with instructions for installing the Cyber-T interface and software. This tutorial lists the functions available as part of the hdarray library and R resources. The library and the Cyber-T Web interface also include routines for analyzing paired samples, which would be produced from two-dye glass-slide microarray experiments (Schena et al., 1995a; Schena et al., 1995b; Shalon et al., 1996; Heller et al., 1997; Lashkari et al., 1997) . The Webbased interface is written in Perl (http://www.perl.com) to pass the data and other information to a series of functions. This combination of a hard-wired front-end Web interface to a exible back end allows users to easily explore their data while simultaneously providing a framework for growth and evolution of non-proprietary analysis routines.
Cyber-T generates three output les, two of which (allgenes.txt and siggenes.txt) can either be viewed in the browser window or downloaded and imported into a spreadsheet application for user-speci c formatting. These les return the original data and a number of additional columns containing summary statistics, including the mean and standard deviation of both raw and log transformed data, estimates of the standard deviations employing the Bayesian prior, t-tests incorporating the Bayesian prior on both the raw and log-transformed data, p-values associated with t-tests, and \signed foldchange" associated with the experiment. The exact content of these les is detailed online. Cyber-T also generates automatically a postscript le CyberT.ps containing a series of graphs that are useful in visualizing the data.
